|
| Asapiprant Basic information |
Product Name: | Asapiprant | Synonyms: | Asapiprant,S-555739;S-555739;S-555739; S 555739; S555739; ASAPIPRANT;932372-01-5;CS-2811;S 555739;S555739;S-555739; S 555739; S555739; ASAPIPRANT;Acetic acid, 2-[5-[4-[[4-(1-methylethoxy)phenyl]sulfonyl]-1-piperazinyl]-2-(2-oxazolyl)phenoxy]- | CAS: | 932372-01-5 | MF: | C24H27N3O7S | MW: | 501.55 | EINECS: | | Product Categories: | APIS | Mol File: | 932372-01-5.mol | |
| Asapiprant Chemical Properties |
Melting point | >218°C (dec.) | Boiling point | 731.6±70.0 °C(Predicted) | density | 1.341±0.06 g/cm3(Predicted) | storage temp. | -20°C Freezer, Under inert atmosphere | solubility | Chloroform (Slightly), DMSO (Slightly) | pka | 2.92±0.10(Predicted) | form | Solid | color | White to Off-White |
| Asapiprant Usage And Synthesis |
Uses | Asapiprant is a DP1 receptor antagonist, used in the treatment of asthma. |
| Asapiprant Preparation Products And Raw materials |
|